Drug Trial Radar · NCT07065240
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
360
Planned (sponsor's estimate)
Start
Jun 19, 2025
Primary completion
Mar 2027
Study completion Mar 2027
Sponsor
- Lead sponsor
- Seaport TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- Premier Research
- First posted
- Jul 15, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, parallel-group, double-blind, placebo-controlled, monotherapy study to evaluate the efficacy, safety, and tolerability of SPT-300 (GlyphAllo) in adults with major depressive disorder (MDD), with or without anxious distress.
Conditions
- Major Depressive Disorder (MDD)
- Major Depressive Disorder With Anxious Distress
Interventions
SPT-300Drug
A prodrug of allopregnanolone, a small molecule drug
PlaceboDrug
Placebo for SPT-300
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Day 42 in Hamilton Depression Rating Scale-17 (HAM-D-17) Total ScoreTime frame: Baseline (Day 0) to Day 42
Locations
62 sites in 7 countries. Site status is shown where the registry gives one.
Seaport Investigator Site
Chino, California · Recruiting
Seaport Investigator Site
Garden Grove, California · Recruiting
Seaport Investigator Site
Glendale, California · Recruiting
Seaport Investigator Site
Redlands, California · Recruiting
Seaport Investigator Site
San Jose, California · Recruiting
Seaport Investigator Site
Cromwell, Connecticut · Recruiting
Seaport Investigator Site
Jacksonville, Florida · Recruiting
Seaport Investigator Site
Lauderhill, Florida · Recruiting
Seaport Investigator Site
Orlando, Florida · Recruiting
Seaport Investigator Site
Palm Bay, Florida · Recruiting
Seaport Investigator Site
West Palm Beach, Florida · Recruiting
Seaport Investigator Site
Atlanta, Georgia · Recruiting
Seaport Investigator Site
Decatur, Georgia · Recruiting
Seaport Investigator Site
Marietta, Georgia · Withdrawn
Seaport Investigator Site
Boston, Massachusetts · Recruiting
Seaport Investigator Site
Boston, Massachusetts · Withdrawn
Seaport Investigator Site
Russells Mills, Massachusetts · Recruiting
Seaport Investigator Site
St Louis, Missouri · Recruiting
Seaport Investigator Site
Brooklyn, New York · Recruiting
Seaport Investigator Site
Cedarhurst, New York · Recruiting
Seaport Investigator Site
New York, New York · Recruiting
Seaport Investigator Site
Staten Island, New York · Recruiting
Seaport Investigator Site
Independence, Ohio · Recruiting
Seaport Investigator Site
North Canton, Ohio · Recruiting
Seaport Investigator Site
Allentown, Pennsylvania · Recruiting
Seaport Investigator Site
Dallas, Texas · Recruiting
Seaport Investigator Site
Irving, Texas · Recruiting
Seaport Investigator Site
Richardson, Texas · Recruiting
Seaport Investigator Site
Everett, Washington · Recruiting
Seaport Investigator Site
Lovech, Bulgaria · Recruiting
Seaport Investigator Site
Plovdiv, Bulgaria · Recruiting
Seaport Investigator Site
Sofia, Bulgaria · Recruiting
Seaport Investigator Site
Sofia, Bulgaria · Withdrawn
Seaport Investigator Site
Brno, Czechia · Recruiting
Seaport Investigator Site
Pilsen, Czechia · Recruiting
Seaport Investigator Site
Prague, Czechia · Recruiting
Seaport Investigator Site
Prague, Czechia · Recruiting
Seaport Investigator Site
Prague, Czechia · Recruiting
Seaport Investigator Site
Prague, Czechia · Recruiting
Seaport Investigator Site
Bad Homburg, Germany · Recruiting
Showing 40 of 62 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.